Functional Assessment Of Challenging Behavior And Neurological & Cardio- Pulmonary Problem In Patients With Autism Syndrome: Diagnosis And Treatment

Authors

  • Amirhossein Maleki , Mohsen Noorbakhsh , Aram Farhoudian , Sara Hassani , Shima Aminoroaya Karladani

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.497

Abstract

This article examines and functionally evaluates the challenging behavior and cardiopulmonary problems of patients with autism syndrome: Diagnosis and treatment. Autism spectrum disorder (ASD) is a broad term used to describe a group of neurodevelopmental disorders. These disorders are characterized by communication and social interaction problems. Individuals with ASD often exhibit restricted, repetitive, and stereotyped symptoms or behavior patterns. Autism is more common in boys than girls, with a ratio of 4 males to 1 female. There is evidence that the cases of ASD are increasing. Some attribute this increase to environmental factors. However, experts debate whether there is a real increase in cases or whether there are just more frequent diagnoses. Symptoms of autism are usually evident in early childhood, between 12 and 24 months of age. However, symptoms may appear sooner or later. Early symptoms may include significant delays in language or social development. Autism symptoms are divided into two categories: Communication and social interaction problems and limited or repetitive patterns of behavior or activities. Gluten protein is found in wheat, barley and other grains. These consultants believe that gluten causes inflammation and side effects in certain people with ASD. Research has shown that 11% of people with autism are hospitalized before reaching adulthood. Various diseases such as epilepsy, anxiety, digestive problems or sleep problems occur together with autism.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

Functional Assessment Of Challenging Behavior And Neurological & Cardio- Pulmonary Problem In Patients With Autism Syndrome: Diagnosis And Treatment. (2022). Journal of Pharmaceutical Negative Results, 4112-4136. https://doi.org/10.47750/pnr.2022.13.S10.497